BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 19630074)

  • 1. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.
    García-León JA; Pinto-Medel MJ; García-Trujillo L; López-Gómez C; Oliver-Martos B; Prat-Arrojo I; Marín-Bañasco C; Suardíaz-García M; Maldonado-Sanchez R; Fernández-Fernández O; Leyva-Fernández L
    Mol Immunol; 2011 Sep; 48(15-16):1896-902. PubMed ID: 21665278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.
    Miyashita R; Tsuchiya N; Yabe T; Kobayashi S; Hashimoto H; Ozaki S; Tokunaga K
    Arthritis Rheum; 2006 Mar; 54(3):992-7. PubMed ID: 16508981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
    Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of KIR genes in the Iranian population.
    Tajik N; Shahsavar F; Mousavi T; Radjabzadeh MF
    Tissue Antigens; 2009 Jul; 74(1):22-31. PubMed ID: 19392787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
    Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos.
    Contreras G; Aláez C; Murguía A; García D; Flores H; Gorodezky C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():125-9. PubMed ID: 17445185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.
    Kröger N; Binder T; Zabelina T; Wolschke C; Schieder H; Renges H; Ayuk F; Dahlke J; Eiermann T; Zander A
    Transplantation; 2006 Oct; 82(8):1024-30. PubMed ID: 17060849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
    Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIRs and their HLA ligands in remitting-relapsing multiple sclerosis.
    Fusco C; Guerini FR; Nocera G; Ventrella G; Caputo D; Valentino MA; Agliardi C; Gallotti J; Morra VB; Florio C; Clerici M; Lombardi ML
    J Neuroimmunol; 2010 Dec; 229(1-2):232-7. PubMed ID: 20826009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
    Middleton D; Diler AS; Meenagh A; Sleator C; Gourraud PA
    Tissue Antigens; 2009 Jun; 73(6):553-60. PubMed ID: 19493232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
    Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR2DS3 is associated with protection against acute myeloid leukemia.
    Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
    Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
    Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
    PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIR genes and HLA class I ligands in Gaucher disease.
    Vairo F; Portela P; Salim PH; Jobim M; Netto C; Dorneles A; Mittlestadt S; Jobim LF; Schwartz IV
    Gene; 2013 Mar; 516(1):53-7. PubMed ID: 23266622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of KIR genes with Behcet's disease.
    Middleton D; Meenagh A; Sleator C; Gourraud PA; Ayna T; Tozkir H; Köse AA; Azizleri G; Diler AS
    Tissue Antigens; 2007 Nov; 70(5):435-8. PubMed ID: 17868255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
    Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
    Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
    Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.